Notes
including required food and programme fees for the lifestyle/food replacement interventions, and medication and physician visits for the pharmaceutical interventions (2013 values)
Reference
Finkelstein EA, et al. Meta- and cost-effectiveness analysis of commercial weight loss strategies. Obesity (Silver Spring, Md.) : 24 Jun 2014. Available from: URL: http://doi.org/10.1002/oby.20824
Rights and permissions
About this article
Cite this article
The skinny on phentermine/topiramate for obesity. PharmacoEcon Outcomes News 708, 8 (2014). https://doi.org/10.1007/s40274-014-1430-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1430-x